2022
Bayesian local exchangeability design for phase II basket trials
Liu Y, Kane M, Esserman D, Blaha O, Zelterman D, Wei W. Bayesian local exchangeability design for phase II basket trials. Statistics In Medicine 2022, 41: 4367-4384. PMID: 35777367, PMCID: PMC10279458, DOI: 10.1002/sim.9514.Peer-Reviewed Original Research
2018
Semi-supervised identification of cancer subgroups using survival outcomes and overlapping grouping information
Wei W, Sun Z, da Silveira W, Yu Z, Lawson A, Hardiman G, Kelemen L, Chung D. Semi-supervised identification of cancer subgroups using survival outcomes and overlapping grouping information. Statistical Methods In Medical Research 2018, 28: 2137-2149. PMID: 29336210, PMCID: PMC6922004, DOI: 10.1177/0962280217752980.Peer-Reviewed Original ResearchMeSH KeywordsAlgorithmsAustraliaDatabases, FactualFemaleGenomicsHumansOvarian NeoplasmsSurvival AnalysisConceptsCancer subgroupsAustralian Ovarian Cancer StudyHigh-grade serous ovarian cancerCancer patient subgroupsSerous ovarian cancerMolecular featuresOvarian Cancer StudyCancer Genome AtlasSurvival outcomesTreatment of cancerCancer patientsPatient subgroupsOvarian cancerPersonalized treatmentCancer progressionGenome AtlasCancer studiesKey molecular featuresSubgroupsCancerClear benefitTreatmentPatientsClinicians